Timing of extracorporeal shock wave therapy in rabbits with carpal tunnel syndrome

Abstract

The purpose of this study is to evaluate the effect ofextracorporealshockwavetherapy(ESWT) according to treatmenttiminginrabbitswith 10% dextrose-inducedcarpaltunnelsyndrome(CTS); 0.1-ml 10% dextrose solution was injected under ultrasound guidance twice weekly to the left forepaw subsynovial connective tissue (SSCT) within thecarpaltunnelof 36 New Zealand whiterabbitsto induce CTS. Therabbitswere randomly allocated into four groups: G1-S (sham ESWT), G2-E4 (ESWT at 4weeks), G3-E8 (at 8weeks), and G4-E16 (at 16weeks). Radial ESWT (500 pulses, 0.08mJ/mm2, 2Hz) was repeated thrice weekly. Median nerve distal motor latency (DML) was measured before injection and at 4, 8, 12, 16, and 20weeks after the first injection. Allrabbitswere sacrificed 20weeks after injection. The median nerve cross-sectional area (CSA) and SSCT thickness were measured with light microscopy. The mean median nerve DML at 4weeks after the first dextrose injection did not differ from that at preinjection in all groups. The mean median nerve DML significantly increased before ESWT in all groups (p<.05); however, it did not increase in G2-E4 and G3-E8 for 12weeks after ESWT and in G4-E16 for 4weeks (p>.05). Mean CSA of the median nerve and mean SSCT thickness in G2-E4 were significantly lower than those in the other groups (p<.05). ESWT may prevent the progression of CTS for 12weeks inrabbitswith dextrose-induced CTS regardless of treatmenttiming, and early application results in superior outcomes.